Has Aviva Abosch, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,884 in general payments to Aviva Abosch, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aviva Abosch, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aviva Abosch, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aviva Abosch, MD

Neurological Surgery · Miami, FLNPI 1023062999

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,150 of the $40,884 with a category attached, or 76.2%. Medtronic accounts for 99.2% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $22,740, 2.3 times the $9,837 reported in 2019.

$40,884in general payments, 2019–2025

Across 32 payments — averaging $1277.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$41K
Boston Scientific$174
Neuropace, Inc.$149

$154,298in research payments, 2019–2025

Across 10 payments — averaging $15,430 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$154K

What the payments were for

Consulting fees$31,15076%
Speaking & faculty fees$6,58616%
Travel & lodging$2,2305%
Food & beverage$9182%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	29	$40,561
Boston Scientific	2	$174
Neuropace, Inc.	1	$149

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,884 in reported general payments places this provider in the 75th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$76,468

Medicare patients

Services billed

122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Miami

Eric PetersonMiami$10.1M
Michael WangMiami$2.2M
Wilson AsforaMiami$1.3M
Steven VanniMiami$1.1M
Timur UrakovMiami$652K
Samuel GoldsmitMiami$519K
Robert StarkeMiami$302K
Ian CoteMiami$231K
Michael IvanMiami$225K
James GuestMiami$155K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →